Sökning: id:"swepub:oai:gup.ub.gu.se/253695" > Early treatment wit...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05393naa a2200505 4500 | |
001 | oai:gup.ub.gu.se/253695 | |
003 | SwePub | |
008 | 240910s2017 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/2536952 URI |
024 | 7 | a https://doi.org/10.1111/aas.128612 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Oras, Jonatan,d 1978u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för anestesiologi och intensivvård,Institute of Clinical Sciences, Department of Anesthesiology and Intensive care4 aut0 (Swepub:gu)xorajo |
245 | 1 0 | a Early treatment with isoflurane attenuates left ventricular dysfunction and improves survival in experimental Takotsubo |
264 | c 2017-02-10 | |
264 | 1 | b Wiley,c 2017 |
520 | a BackgroundTakotsubo syndrome (TS) is an acute cardiac condition, often triggered by critical illness, for which no specific treatment exists. Previously, we showed that isoflurane can prevent experimental TS. The aim of this study was to evaluate the potential treatment effects of isoflurane. Our primary hypothesis was that early treatment with isoflurane attenuates left ventricular akinesia in experimental TS. MethodIn propofol-sedated animals, TS was induced by an intraperitoneal bolus of isoprenaline (50 mg/kg). Animals were randomized to one of six groups (n = 15 in each group), and 1% isoflurane was administered for 90 min in all groups. Isoflurane treatment was started at 0, 10, 30 (early treatment) or 120 (late treatment) minutes after isoprenaline injection. One additional late treatment group received isoflurane 0.5% for 180 min. A control group did not receive isoflurane. Left ventricular (LV) echocardiographic examination was performed at 90 min and 48 h after isoprenaline. Mortality was assessed at 48 h. ResultsMedian degree of LV akinesia at 90 min was 24% in the control group and 0% in the early treatment groups (P < 0.001). Stroke volume, cardiac output and LV ejection fraction were higher in the early treatment groups vs. controls (P < 0.01). Mortality was lower in the early treatment groups (24%) vs. controls (86%) (P < 0.001). Mortality did not differ between the late treatment groups and controls. ConclusionEarly treatment with isoflurane attenuates the LV akinesia and improves survival in experimental TS. Isoflurane sedation in patients at risk of developing Takotsubo syndrome could be a subject for future studies. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Anestesi och intensivvård0 (SwePub)302012 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Anesthesiology and Intensive Care0 (SwePub)302012 hsv//eng |
653 | a stress-induced cardiomyopathy | |
653 | a intensive-care patients | |
653 | a subarachnoid | |
653 | a hemorrhage | |
653 | a rat model | |
653 | a volatile anesthetics | |
653 | a cardiac dysfunction | |
653 | a heart-failure | |
653 | a sedation | |
653 | a propofol | |
653 | a cardioprotection | |
700 | 1 | a Redfors, Björnu Gothenburg University,Göteborgs universitet,Center for Cardiovascular and Metabolic Research (CMR),Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xredbj |
700 | 1 | a Gasim Elsied, Anwar Aliu Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Wallenberg Laboratory,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xgasan |
700 | 1 | a Alkhoury, Jessica,d 1988u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Wallenberglaboratoriet,Institute of Medicine, Department of Molecular and Clinical Medicine,Wallenberg Laboratory4 aut0 (Swepub:gu)xalkdj |
700 | 1 | a Seeman-Lodding, Heléne,d 1957u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för anestesiologi och intensivvård,Institute of Clinical Sciences, Department of Anesthesiology and Intensive care4 aut0 (Swepub:gu)xseehe |
700 | 1 | a Omerovic, Elmir,d 1968u Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Center for Cardiovascular and Metabolic Research (CMR),Wallenberg Laboratory4 aut0 (Swepub:gu)xomeel |
700 | 1 | a Ricksten, Sven-Erik,d 1953u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för anestesiologi och intensivvård,Institute of Clinical Sciences, Department of Anesthesiology and Intensive care4 aut0 (Swepub:gu)xricsv |
710 | 2 | a Göteborgs universitetb Institutionen för kliniska vetenskaper, Avdelningen för anestesiologi och intensivvård4 org |
773 | 0 | t Acta Anaesthesiologica Scandinavicad : Wileyg 61:4, s. 399-407q 61:4<399-407x 0001-5172 |
856 | 4 8 | u https://gup.ub.gu.se/publication/253695 |
856 | 4 8 | u https://doi.org/10.1111/aas.12861 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy